Correspondence 0001193125-24-201298 from Repare Therapeutics Inc. (RPTX) (CIK 0001808158)
Repare Therapeutics Inc. (RPTX) (CIK 0001808158)
Date: Aug. 15, 2024 · CIK: 0001808158 · Accession: 0001193125-24-201298
AI Filing Summary & Sentiment
File numbers found in text: 333-281298
Letter
Acceleration Request
REPARE THERAPEUTICS INC.
7171 Frederick-Banting, Building 2
Suite 270
St-Laurent, Québec H4S 1Z9
Canada
August 15, 2024
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Repare Therapeutics Inc.
Registration Statement on Form S-3
File No. 333-281298
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, Repare Therapeutics Inc. (the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-281298) (the “Registration Statement”) to become effective at 4:00 p.m., Eastern Time, on Monday, August 19, 2024, or as soon as practicable thereafter, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission (the “Staff”). The Registrant hereby authorizes Courtney T. Thorne of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Courtney T. Thorne of Cooley LLP at (617) 937-2318, or, in her absence, Trey Reilly of Cooley LLP at (212) 479-6502.
Very
truly yours,
REPARE THERAPEUTICS INC.
Show Raw Text
CORRESP 1 filename1.htm Acceleration Request REPARE THERAPEUTICS INC. 7171 Frederick-Banting, Building 2 Suite 270 St-Laurent, Québec H4S 1Z9 Canada August 15, 2024 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Repare Therapeutics Inc. Registration Statement on Form S-3 File No. 333-281298 Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, Repare Therapeutics Inc. (the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-281298) (the “Registration Statement”) to become effective at 4:00 p.m., Eastern Time, on Monday, August 19, 2024, or as soon as practicable thereafter, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission (the “Staff”). The Registrant hereby authorizes Courtney T. Thorne of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with Courtney T. Thorne of Cooley LLP at (617) 937-2318, or, in her absence, Trey Reilly of Cooley LLP at (212) 479-6502. Very truly yours, REPARE THERAPEUTICS INC. /s/ Steve Forte By: Steve Forte Title: Executive Vice President, Chief Financial Officer cc: Lloyd M. Segal, Repare Therapeutics Inc. Divakar Gupta, Cooley LLP Courtney T. Thorne, Cooley LLP Trey Reilly, Cooley LLP